Search for Clinical Trial Results
Febrile Neutropenia - 37 Studies Found
Status | Study |
Completed |
Study Name: Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options Condition: Febrile Neutropenia Date: 2009-07-23 Interventions: Drug: Antibacterial agent for the treatment of febrile neutropenia The antibacterial agent used by the i |
Completed |
Study Name: Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia Condition: Patients With Febrile Neutropenia Date: 2014-08-08 Interventions:
|
Terminated |
Study Name: Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics Condition: Febrile Neutropenia Date: 2007-01-08 Interventions:
|
Completed |
Study Name: Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. Condition: Chemotherapy-induced Febrile Neutropenia Date: 2013-01-08 |
Completed |
Study Name: Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation Condition:
|
Completed |
Study Name: Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia Condition: Febrile Neutropenia Date: 2008-07-24 |
Not yet recruiting |
Study Name: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer Condition: Febrile Neutropenia Date: 2017-02-24 Interventions: Drug: EC-18 oral administration Other Name: EC-18 so |
Not yet recruiting |
Study Name: Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia Condition:
Date: 2015-05-26 Interventions:
|
Completed |
Study Name: Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy Condition: Chemotherapy-induced Febrile Neutropenia Date: 2014-06-10 |
Recruiting |
Study Name: Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO Condition:
Date: 2014-05-19 Interventions: Drug: Discontinuation of imipenem-cilastatin or meropenem Discontinuation of imipenem-cilastatin or mero |